HGH Fragment 176-191 news and clinical trials
Also known as: HGH Frag 176-191 · HGH Frag · hGH 176-191 · Fragment 176-191 · Frag 176-191 · Frag 176 · GH fragment 176-191
Updated 33 sources
2 new studies in the last 12 months, newest first: trial registrations and results, PubMed papers, FDA actions and press coverage that name HGH Fragment 176-191. Each line links to the primary source.
July 2026
- StudyPubMedThe emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration (opens PubMed)
A review of peptides modulating the GH-IGF-1 axis highlights the significant gap between clinical evidence and unregulated self-administration protocols. Clinicians are advised to recognize potential adverse effects like endocrine disturbances, fluid retention, and metabolic issues.
Frontiers in endocrinologyReviewPMID 42395176
June 2026
- StudyPubMedRapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices (opens PubMed)
Researchers reported a fast analytical workflow to detect 54 prohibited doping compounds in dried blood spots, serum, and plasma using liquid chromatography and mass spectrometry. The study found that storing samples in dried matrices allows for non-refrigerated transport, reducing costs.
The AnalystPMID 42328738
Searched as: HGH Frag, hGH 176-191, Fragment 176-191, Frag 176. Summaries are one or two sentences, published only when every number in them appears in the source record. A tracker, not medical advice.